The GM values of the sCD163 CSF/serum ratio was significantly increased in RRMS (p<.001), CIS (p = 0.011), and especially the PPMS group in which the GM value was elevated by 56% (p<0.001). This evidence concerns the gene CD163 and in situ carcinoma.